Issues related to Medicare reimbursement for biological products.
2025 · 4th Quarter (Oct 1 - Dec 31)
HUMACYTE
Filed by CAPITOL HILL CONSULTING GROUP.
Open official filingSource-reported fields
Filing overview
- Type
- 4th Quarter - Report
- Posted
- Jan 20, 2026
- Income
- $50,000.00
- Expenses
- Not reported
- Registrant
- CAPITOL HILL CONSULTING GROUP
- Client
- HUMACYTE
- Filing UUID
- aec91060-c75b-41c1-8b24-4555cd775141
- Termination date
- Not reported
Literal source text
Lobbying issues and bill citations
Issues related to Medicare reimbursement for biological products. Issues related to supporting access to biologic products to treat warfighters.
Supporting funding for procurement of biologic products to treat post-combat trauma. Issues related to supporting access to biologic products to treat warfighters.
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.